[go: up one dir, main page]

DK104991A - EXPRESSION OF HIV PROTEINS IN DROSOPHILA CELLS - Google Patents

EXPRESSION OF HIV PROTEINS IN DROSOPHILA CELLS Download PDF

Info

Publication number
DK104991A
DK104991A DK104991A DK104991A DK104991A DK 104991 A DK104991 A DK 104991A DK 104991 A DK104991 A DK 104991A DK 104991 A DK104991 A DK 104991A DK 104991 A DK104991 A DK 104991A
Authority
DK
Denmark
Prior art keywords
expression
hiv proteins
drosophila cells
drosophila
hiv
Prior art date
Application number
DK104991A
Other languages
Danish (da)
Other versions
DK175461B1 (en
DK104991D0 (en
Inventor
Hanne Ranch Johansen
Martin Rosenberg
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of DK104991A publication Critical patent/DK104991A/en
Publication of DK104991D0 publication Critical patent/DK104991D0/en
Application granted granted Critical
Publication of DK175461B1 publication Critical patent/DK175461B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/75—Vector systems having a special element relevant for transcription from invertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK104991A 1988-12-01 1991-05-31 Expression of HIV proteins in Drosophila cells DK175461B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27838688A 1988-12-01 1988-12-01
US27838688 1988-12-01
PCT/US1989/005155 WO1990006358A1 (en) 1988-12-01 1989-11-29 Expression of hiv proteins in drosophila cells
US8905155 1989-11-29

Publications (3)

Publication Number Publication Date
DK104991A true DK104991A (en) 1991-05-31
DK104991D0 DK104991D0 (en) 1991-05-31
DK175461B1 DK175461B1 (en) 2004-11-01

Family

ID=23064787

Family Applications (1)

Application Number Title Priority Date Filing Date
DK104991A DK175461B1 (en) 1988-12-01 1991-05-31 Expression of HIV proteins in Drosophila cells

Country Status (12)

Country Link
EP (1) EP0446272A4 (en)
JP (1) JP3085704B2 (en)
KR (1) KR0152525B1 (en)
AU (1) AU630649B2 (en)
CA (1) CA2003794C (en)
DK (1) DK175461B1 (en)
FI (1) FI113475B (en)
IL (1) IL92470A (en)
NO (1) NO314090B1 (en)
PT (1) PT92477A (en)
WO (1) WO1990006358A1 (en)
ZA (1) ZA899150B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2841376C (en) * 2011-07-05 2023-02-28 Duke University N-terminal deleted gp120 immunogens
WO2013052095A2 (en) 2011-10-03 2013-04-11 Duke University Vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0272858A3 (en) * 1986-12-15 1989-07-12 Repligen Corporation Recombinant hiv envelope proteins produced in insect cells
CA1341345C (en) * 1987-05-08 2002-03-05 Hanne Ranch Johansen Expression of foreign genes in drosophila cells
AP129A (en) * 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
KR910700352A (en) * 1988-12-21 1991-03-14 스미스클라인 바이올로지칼즈(s.a.) Expression of Plasmodium Circus Sporozoite Protein in Insect Cells

Also Published As

Publication number Publication date
EP0446272A1 (en) 1991-09-18
AU4755290A (en) 1990-06-26
CA2003794A1 (en) 1990-06-01
WO1990006358A1 (en) 1990-06-14
PT92477A (en) 1990-06-29
NO912099D0 (en) 1991-05-31
AU630649B2 (en) 1992-11-05
EP0446272A4 (en) 1993-01-07
CA2003794C (en) 2000-02-08
KR910700344A (en) 1991-03-14
NO314090B1 (en) 2003-01-27
DK175461B1 (en) 2004-11-01
FI113475B (en) 2004-04-30
IL92470A0 (en) 1990-08-31
IL92470A (en) 1997-01-10
KR0152525B1 (en) 1998-10-01
NO912099L (en) 1991-07-31
JPH04501954A (en) 1992-04-09
DK104991D0 (en) 1991-05-31
JP3085704B2 (en) 2000-09-11
FI912635A0 (en) 1991-05-31
ZA899150B (en) 1991-04-24

Similar Documents

Publication Publication Date Title
DK0383569T3 (en) Storage of materials
DE69433168D1 (en) IN VITRO PROPAGATION OF STEM CELLS
MX163651B (en) ELECTROCHEMICAL CELL
DK234087D0 (en) EXPRESSION OF A PROTEIN IN Mammalian Cells
DK280787A (en) INDUCTION OF GALACTOSE-REGULATED GENE EXPRESSION IN GAER
DK85589A (en) EXPRESSION OF HIV BINDING PROTEINS
DK354885A (en) DETERMINATION OF CELL MEMBRANE PROTEIN
DE68914571D1 (en) Electrical insertion of proteins in membranes of animal cells.
DK199689A (en) EXPRESSION OF HUMANT INTERLEUKIN-2 IN METHYLOTROPHIC GAERTS
DK440289D0 (en) FUEL CELL
FI880636A0 (en) FOERFARANDE FOER INAKTIVERING AV MED HOELJE FOERSEDDA VIRUS I EN MEDELST EN CELL IN VITRO FRAMSTAELLDA PROTEINPRODUKTER.
DK104991A (en) EXPRESSION OF HIV PROTEINS IN DROSOPHILA CELLS
DE3676604D1 (en) EXPRESSION OF EPA IN MAMMAL CELLS.
DK196689A (en) EXPRESSION OF THE PRAES2 PROTEIN FOR HEPATITIS B IN METHYLOTROPHIC GAERTS
DK562289A (en) USE OF SOMATO STATINES
DK643188D0 (en) EXPRESSION OF HIV PROTEINS IN E.COLI AND S.CEREVISIAE
DK41585D0 (en) EXPRESSION OF HUMAN ALFA-1-ANTITRYPSIN IN GAER
DK541487A (en) SUMMARY OF MATERIALS
DK187790A (en) EXPRESSION OF PLASM MODULE CIRCUMSPOROZOIT PROTEIN IN INSECT CELLS
ES542141A0 (en) IMPROVEMENTS IN INTRAOCULAR AND SIMILAR PROSTHESES
IE893803L (en) Expression of hiv proteins in drosophila cells
DK289987A (en) USING AVARON AND AVAROLD DERIVATIVES
DK289887A (en) USING AVARON AND AVAROLD DERIVATIVES
ATE59407T1 (en) EXPRESSION OF EPA IN MAMMALIAN CELLS.
DK307190A (en) RINSE OF GAS THROUGH A MELT IN A BASEBAG

Legal Events

Date Code Title Description
PUP Patent expired